An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults

被引：33

作者：

Talaat, Kawsar R. ^{[1
]}

Karron, Ruth A. ^{[1
]}

Luke, Catherine J. ^{[2
]}

Thumar, Bhagvanji ^{[1
]}

McMahon, Bridget A. ^{[1
]}

Chen, Grace L. ^{[2
]}

Lamirande, Elaine W. ^{[2
]}

Jin, Hong ^{[3
]}

Coelingh, Kathy L. ^{[3
]}

Kemble, George ^{[3
]}

Subbarao, Kanta ^{[2
]}

机构：

[1] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Immunizat Res, Baltimore, MD 21205 USA

[2] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA

[3] MedImmune, Mountain View, CA 94043 USA

来源：

VACCINE | 2011年 / 29卷 / 17期

关键词：

H6N1; Avian influenza; Vaccine; Live attenuated; A H5N1 VIRUS; HUMAN INFECTION; SOUTHERN CHINA; HONG-KONG; H9N2; RESPONSES; ANTIBODY; HUMANS; VOLUNTEERS; CHICKENS;

D O I：

10.1016/j.vaccine.2011.02.043

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Background: We describe the results of an open label Phase I trial of a live attenuated H6N1 influenza virus vaccine (ClinicalTrials.gov Identifier: NCT00734175). Methods and findings: We evaluated the safety, infectivity, and immunogenicity of two doses of 10(7) TCID50 of the H6N1 Teal HK 97/AA ca vaccine, a cold-adapted and temperature sensitive live, attenuated influenza vaccine (LAIV) in healthy seronegative adults. Twenty-two participants received the first dose of the vaccine, and 18 received the second dose of vaccine 4 weeks later. The vaccine had a safety profile similar to that of other investigational LAIVs bearing avian hemagglutinin (HA) and neuraminidase (NA) genes. The vaccine was highly restricted in replication: two participants had virus detectable by rRT-PCR beyond day 1 after each dose. Antibody responses to the vaccine were also restricted: 43% of participants developed a serum antibody response as measured by any assay: 5% by hemagglutination-inhibition assay, 5% by microneutralization assay, 29% by ELISA for H6 HA-specific IgG and 24% by ELISA for H6 HA specific IgA after either 1 or 2 doses. Following the second dose, vaccine specific IgG and IgA secreting cells as measured by ELISPOT increased from a mean of 0.6 to 9.2/10(6) PBMCs and from 0.2 to 2.2/10(6) PBMCs, respectively. Conclusion: The H6N1 LAIV had a safety profile similar to that of LAIV bearing other HA and NA genes, but was highly restricted in replication in healthy seronegative adults. The H6N1 LAIV was also not as immunogenic as the seasonal LAIV. (C) 2011 Elsevier Ltd. All rights reserved.

引用

页码：3144 / 3148

页数：5

共 32 条

[11] Human infection with highly pathogenic H5N1 influenza virus [J].

Gambotto, Andrea ;

Barratt-Boyes, Simon M. ;

de Jong, Menno D. ;

Neumann, Gabriele ;

Kawaoka, Yoshihiro .

LANCET, 2008, 371 (9622) :1464-1475

[12] Evidence for avian influenza A infections among Iowa's agricultural workers [J].

Gray, Gregory C. ;

McCarthy, Troy ;

Capuano, Ana W. ;

Setterquist, Sharon F. ;

Alavanja, Michael C. ;

Lynch, Charles F. .

INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2008, 2 (02) :61-69

[13] Phase I, Randomized, Controlled Trial to Study the Reactogenicity and Immunogenicity of a Nasal, Inactivated Trivalent Influenza Virus Vaccine in Healthy Adults [J].

Halperin, Scott A. ;

Smith, Bruce ;

Clarke, Kevin ;

Treanor, John ;

Mabrouk, Taoufik ;

Germain, Marc .

HUMAN VACCINES, 2005, 1 (01) :37-42

[14] Characterization of the influenza A virus gene pool in avian species in southern China: Was H6N1 a derivative or a precursor of H5N1? [J].

Hoffmann, E ;

Stech, J ;

Leneva, I ;

Krauss, S ;

Scholtissek, C ;

Chin, PS ;

Peiris, M ;

Shortridge, KF ;

Webster, RG .

JOURNAL OF VIROLOGY, 2000, 74 (14) :6309-6315

[15] Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults [J].

Karron, Ruth A. ;

Talaat, Kawsar ;

Luke, Catherine ;

Callahan, Karen ;

Thumar, Bhagvanji ;

DiLorenzo, Susan ;

McAuliffe, Josephine ;

Schappell, Elizabeth ;

Suguitan, Amorsolo ;

Mills, Kimberly ;

Chen, Grace ;

Lamirande, Elaine ;

Coelingh, Kathleen ;

Jin, Hong ;

Murphy, Brian R. ;

Kemble, George ;

Subbarao, Kanta .

VACCINE, 2009, 27 (36) :4953-4960

[16] A Live Attenuated H9N2 Influenza Vaccine Is Well Tolerated and Immunogenic in Healthy Adults [J].

Karron, Ruth A. ;

Callahan, Karen ;

Luke, Catherine ;

Thumar, Bhagvanji ;

McAuliffe, Josephine ;

Schappell, Elizabeth ;

Joseph, Tomy ;

Coelingh, Kathleen ;

Jin, Hong ;

Kemble, George ;

Murphy, Brian R. ;

Subbarao, Kanta .

JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (05) :711-716

[17] Evaluation of real-time PCR versus PCR with liquid-phase hybridization for detection of enterovirus RNA in cerebrospinal fluid [J].

Lai, KKY ;

Cook, L ;

Wendt, S ;

Corey, L ;

Jerome, KR .

JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (07) :3133-3141

[18] Vaccines for pandemic influenza [J].

Luke, CJ ;

Subbarao, K .

EMERGING INFECTIOUS DISEASES, 2006, 12 (01) :66-72

[19] Spatial, temporal, and species variation in prevalence of influenza A viruses in wild migratory birds [J].

Munster, Vincent J. ;

Baas, Chantal ;

Lexmond, Pascal ;

Waldenstrom, Jonas ;

Wallensten, Anders ;

Fransson, Thord ;

Rimmelzwaan, Guus F. ;

Beyer, Walter E. P. ;

Schutten, Martin ;

Olsen, Bjorn ;

Osterhaus, Albert D. M. E. ;

Fouchier, Ron A. M. .

PLOS PATHOGENS, 2007, 3 (05) :630-638

[20] Insertion of a Multibasic Cleavage Motif into the Hemagglutinin of a Low-Pathogenic Avian Influenza H6N1 Virus Induces a Highly Pathogenic Phenotype [J].

Munster, Vincent J. ;

Schrauwen, Eefje J. A. ;

de Wit, Emmie ;

van den Brand, Judith M. A. ;

Bestebroer, Theo M. ;

Herfst, Sander ;

Rimmelzwaan, Guus F. ;

Osterhaus, Albert D. M. E. ;

Fouchier, Ron A. M. .

JOURNAL OF VIROLOGY, 2010, 84 (16) :7953-7960

← 1 2 3 4 →